62 year old male presented with complaints of weight loss, jaundice, and generalized itching for 1 month. Liver function tests on evaluation read as total bilirubin -- 19.3 mg/dl (*n* -- 0.1--1.2 mg/dl), direct bilirubin -- 17.2 mg/dl (n\< 0.3 mg/dl), serum glutamic-oxaloacetic transaminase -- 78 IU/L (*n* -- 8--33), serum glutamic-pyruvic transaminase -- 56 IU/L (*n* -- 4--36), gamma glutamyl transferase -- 48 IU/L (*n* -- 5--40), alkaline phosphatase 236 IU/L (*n* -- 20--130), serum amylase 208 U/L (*n* -- 0--95), and lipase 1240 U/L (*n* -- 23--300). ^18^ F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) scan was done for a suspected diagnosis of cholangiocarcinoma on the basis of ultrasonography elsewhere. On intra-venous contrast enhancement CT, circumferential wall thickening with enhancement was noted in the common bile duct/peri-ampullary region, enlarged sausage-shaped tail of pancreas with homogenous enhancement and peripheral rim of low attenuation was noted and wall thickening in the antropyloric region of the stomach was noted \[black arrows, [Figure 1a](#F1){ref-type="fig"}, [c](#F1){ref-type="fig"} and [e](#F1){ref-type="fig"}\]. The gall bladder was not distended, and there was no evidence of any significant dilatation of the intrahepatic biliary radicles or main pancreatic duct. On fused ^18^ F-FDG PET/CT images, there was increased FDG uptake noted in the common bile duct stricture (maximum standardized uptake value \[SUV~max~\] -- 7.20), tail of the pancreas (SUV~max~-- 4.72), and stomach wall thickening (SUV~max~-- 4.23) \[white arrows [Figure 1b](#F1){ref-type="fig"}, [d](#F1){ref-type="fig"} and [f](#F1){ref-type="fig"}, respectively\]. Rest of the whole-body scan was unremarkable \[[Figure 2](#F2){ref-type="fig"}\]. Based on these atypical findings, a diagnosis of immunoglobulin G4-related disease (IgG4-RD) was suggested, and subsequently done serum IgG4 levels were found to be elevated: 219 mg/dl (normal \<135 mg/dl). Upper gastrointestinal endoscopy was done; ampullary biopsy was suggestive of dense lymphoplasmacytic infiltrate and was negative for any malignancy \[[Figure 3](#F3){ref-type="fig"}\]. The patient subsequently improved symptomatically with a serial decline in bilirubin levels postendoscopic retrograde cholangiopancreatography stenting and medical management with steroids.

![Computed tomography and positron emission tomography/computed tomography images showing cholangitis (a and b), pancreatitis (c and d), and gastritis (e and f)](IJNM-34-335-g001){#F1}

![Maximum intensity projection image showing increased fluorodeoxyglucose uptake in the common bile duct and distal pancreas](IJNM-34-335-g002){#F2}

![Hematoxylin and eosin stain (high power, ×400) of ampullary biopsy suggestive of dense plasmacytic infiltrate](IJNM-34-335-g003){#F3}

The diagnosis of IgG4-RD (often masquerading as malignancy) is complex and based on a combination of clinical, immunological, and histological findings. Clinical findings suggestive of IgG4-RD include clinical history (such as abdominal pain, jaundice, and weight loss), physical examination (jaundice, exophthalmos, enlarged salivary glands/thyroid etc.), and characteristic imaging findings. Immunological findings include IgG4 levels in serum \>135 mg/dl. Histological findings are considered as gold standard for diagnosis and include lymphoplasmacytic infiltration with storiform fibrosis and obliterative phlebitis.\[[@ref1]\] The clinical manifestations are very variable resulting from the effect of inflammation-induced pseudotumors in the affected site. Of the affected sites encountered in this disease, the most common organ described is the pancreas which has characteristic CT imaging findings.\[[@ref2]\] Extrapancreatic involvement of bile ducts is common and usually seen at follow-up or rarely may be seen at presentation.\[[@ref3]\] Studies have also shown that IgG4-positive plasma cells have also been found to be significantly elevated in gastric mucosa in patients with auto-immune pancreatitis.\[[@ref4][@ref5]\]

The last decade has seen an increased utilization of ^18^ F-FDG PET/CT for diagnosis and follow-up of this disease. ^18^ F-FDG PET/CT appears to be especially useful with doubtful/atypical clinical/conventional imaging findings, especially when serum levels of IgG4 levels are not elevated.\[[@ref6][@ref7][@ref8]\] PET/CT can aid in improving the pathological diagnosis by guiding biopsy from the most accessible and metabolically active component of the disease.\[[@ref9]\] A prospective study done by Zhang *et al*. showed that whole-body^18^ F-FDG PET/CT imaging identifies additional organ involvement in 71% of the cases compared to conventional physical examination and CT scans.\[[@ref10]\]

The simultaneous occurrence of pancreatic and extrapancreatic inflammation presented in this report establishes the systemic nature of IgG4-RD, re-emphasizing the need of whole-body PET imaging in this rare but increasingly recognized auto-immune disease.
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